At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 80 enrolled
Drug / intervention
SI-613 +1 morecombination
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Repeated Intra-Articular Injection of SI-613 in Patients With Osteoarthritis of the Knee
In Brief
A Phase 2 clinical trial evaluating SI-613 and Placebo for Osteoarthritis, Knee. Completed, enrolled 80 participants across 10 sites.
Detailed Summary
The objective of the study is to evaluate the efficacy and safety of intra-articular injections of SI-613 compared with placebo for knee OA.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis, Knee
CountriesUnited States
CollaboratorsChiltern International Inc.
Timeline
Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedJul 2017
Enrollment StartOct 2017
Primary CompletionAug 2018
Study CompletionNov 2018
TodayJul 2026
First PostedJul 6, 2017
Enrollment StartOct 19, 2017
Primary CompletionAug 17, 2018
Study CompletionNov 13, 2018
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 9.0 years ago
Interventions
SI-613combination
SI-613 will be repeated intra-articularly administered.
Placebocombination
Placebo will be repeated intra-articularly administered.